ANXA1 and gastric carcinoma: Strong evidence for this process is provided by the finding that the increased expression of Anx-A1 promotes tumour growth, invasion and metastasis in gastric carcinoma[53], melanoma[54], breast cancer[55] and colorectal cancer[56].